Polynucleotides encoding antibodies that bind both IL-17A and IL-17F
US8871467B2 · kind B2 · utility
7Cited by
7References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 5, 2013 |
| Grant date | Oct 28, 2014 |
| Priority date | — |
| Expiry date | Jun 5, 2033 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/809
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to blocking, inhibiting, reducing, antagonizing or neutralizing the activity of IL-17A and IL-17F. IL-17A and IL-17F are cytokines that are involved in inflammatory processes and human disease. The present invention includes antibodies that bind both IL-17A and IL-17F, hybridomas that produce the antibodies, and methods of using the same in inflammation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.